About CNX Therapeutics
CNX Therapeutics is a company based in London (United Kingdom) founded in 2021. CNX Therapeutics has completed 1 acquisition, including Synchrony Pharma. CNX Therapeutics operates in a competitive market with competitors including Cardinal Health, Concordia International, Xiel, Bartec Technologies and SPL Pharma, among others.
- Headquarter London, United Kingdom
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Cnx Therapeutics Limited
- Date of Incorporation 01 May, 1997
- Jurisdiction LONDON, ENGLAND
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of CNX Therapeutics
Unlock access to complete
Funding Insights of CNX Therapeutics
Detailed funding history for CNX Therapeutics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CNX Therapeutics
CNX Therapeutics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Synchrony Pharma.
Investment portfolio details for CNX Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Generic drugs are manufactured by Synchrony Pharma in the UK.
|
Locked | Locked | 2008 | Locked |
Complete acquisition details for CNX Therapeutics
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - CNX Therapeutics
Detailed financials for CNX Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cnx Therapeutics Comparisons
Peer comparison for CNX Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CNX Therapeutics
CNX Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cardinal Health, Concordia International, Xiel, Bartec Technologies and SPL Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Multiple healthcare products and services are provided to organizations.
|
|
| Locked | Locked | Locked |
Distributes specialty pharmaceutical drugs to healthcare providers.
|
|
| Locked | Locked | Locked |
Specialist nuclear medicine and radiotherapy solutions are distributed.
|
|
| Locked | Locked | Locked |
Mediso: Advanced medical imaging systems and radioactive sources
|
|
| Locked | Locked | Locked |
International distribution of specialty medicines and pharmaceutical market access services.
|
Detailed competitors of CNX Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cnx Therapeutics
Complete news archive for CNX Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CNX Therapeutics
CNX Therapeutics was founded in 2021.
CNX Therapeutics is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
CNX Therapeutics was founded in 2021 and is based in London, United Kingdom. Operations are centered on the distribution of specialty drugs within the pharmaceutical sector. Therapeutic products are supplied to healthcare providers and institutions across the region. The companys domain, cnx-therapeutics.com, supports its online activities. Focus is placed on efficient logistics and regulatory compliance in drug handling. (62 words).
CNX Therapeutics's top competitors include Cardinal Health, Xiel and Bartec Technologies.
CNX Therapeutics has made 1 acquisition, including Synchrony Pharma.